Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Checkpoint Inhibitors Assessment in Oropharynx Carcinoma (CIAO)

NCT03144778 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03144778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03144778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Checkpoint Inhibitors Assessment in Oropharynx Carcinoma (CIAO)
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Completed
Start date
July 12, 2017
Completion date
March 15, 2021
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ii oropharyngeal squamous cell carcinoma ajcc v6 and v7, stage iii oropharyngeal squamous cell carcinoma ajcc v7, stage iva oropharyngeal squamous cell carcinoma ajcc v7